Similarly, Santala et al. reported, that only ACE inhibitors are associated with improved long term ovarian cancer survival when the effect of cardiovascular mortality is taken into account (HR 0.73 95% CI: 0.58–0.91) [6]. This evidence concerns the gene ACE and ovarian cancer.